Why You Still Have Hypothyroidism Symptoms With Normal Labs

Imagine this: you've been diagnosed with hypothyroidism. You diligently take your levothyroxine every morning, an hour before coffee, just as instructed. Your follow-up bloodwork comes back, and your doctor tells you the good news—your Thyroid-Stimulating Hormone (TSH) level is now squarely within the normal range. Yet, the debilitating fatigue, the mental fog, the persistent chill, and the difficulty managing your weight haven't disappeared. If your lab results are normal, why do you still feel unwell?

This frustrating gap between lab values and real-world well-being is a common experience for many people managing an underactive thyroid. The answer often lies beyond a single TSH value, deep within your body's complex hormonal symphony and the genetic instructions that conduct it. For a significant number of individuals, the standard approach to diagnosis and treatment overlooks a critical step: the conversion of inactive thyroid hormone into its active form. Understanding this process—and the genetic factors that influence it—can be the key to finally feeling like yourself again.

The Diagnostic Triangle: TSH, Free T4, and Antibodies

When a doctor suspects an issue with your thyroid, they typically start with a panel of blood tests. While dozens of markers can be assessed, the initial investigation usually focuses on three key players.

First is the Thyroid-Stimulating Hormone (TSH). Produced by the pituitary gland in your brain, TSH acts like a messenger, telling your thyroid gland to produce more hormone. If your thyroid is sluggish (hypothyroid), your pituitary shouts louder, releasing more TSH to compensate. Therefore, a high TSH level is the classic indicator of primary hypothyroidism. The challenge, however, lies in what is considered "normal." While most labs define the TSH normal range as roughly 0.4 to 4.5 mU/L, many endocrinology guidelines and patient experiences suggest that a much narrower range—perhaps under 2.5 mU/L—is optimal for feeling well (Garber et al., 2012). This is why you can be technically "in range" but still symptomatic.

Next is Free T4 (Thyroxine). This measures the main hormone produced directly by your thyroid gland. It's the "free" portion—not bound to proteins—that is available for your body to use. In overt hypothyroidism, Free T4 levels are low. However, in early or subclinical hypothyroidism, T4 can still be within the normal lab range while TSH is already elevated, as the body is successfully compensating for the failing gland.

Finally, and crucially, are the Thyroid Peroxidase Antibodies (anti-TPO). These are not hormones but rather proteins made by your immune system. Thyroid peroxidase is a critical enzyme the thyroid gland uses to produce hormones. When your immune system mistakenly creates antibodies against this enzyme, it signals an autoimmune attack on your own thyroid tissue. The presence of anti-TPO antibodies is the hallmark of Hashimoto's thyroiditis, the leading cause of hypothyroidism in regions with adequate iodine intake.

What is Hashimoto's Thyroiditis?

Many people use the terms "hypothyroidism" and "Hashimoto's" interchangeably, but they aren't the same. Hypothyroidism is the condition of having an underactive thyroid. Hashimoto's is the cause of that condition for an estimated 90% of cases in the developed world.

Hashimoto's thyroiditis is an autoimmune disease. Your body’s defense system, which should be fighting off viruses and bacteria, turns against you and begins to systematically damage the cells of your thyroid gland. This is a slow, progressive process. In the early stages, your thyroid may still function normally, and your TSH and T4 levels might be perfect. You might not have any thyroid symptoms. But the presence of anti-TPO antibodies reveals the hidden battle taking place.

Why does this happen? The predisposition to autoimmune diseases, including Hashimoto's, is strongly linked to genetics. Scientists have identified several genes that increase a person's risk. These genes are not deterministic—having them doesn't guarantee you'll develop the disease—but they create a vulnerability. Key genes involved in immune system regulation, such as those in the Human Leukocyte Antigen (HLA) complex and others like CTLA4 and PTPN22, are consistently associated with a higher risk for Hashimoto's (Zivanovic & Stamenkovic, 2017). An environmental trigger, such as a viral infection, stress, or exposure to certain chemicals, can then set the autoimmune process in motion in a genetically susceptible person.

When "Normal" Isn't Enough: The T4 to T3 Conversion Problem

Here we arrive at the core of why so many people on standard treatment still struggle. Your thyroid gland primarily produces T4, which is largely an inactive storage hormone. For your body to get energy, regulate your metabolism, and maintain cognitive function, that T4 must be converted into T3 (Triiodothyronine), the active, powerful form of thyroid hormone.

This conversion doesn't happen in the thyroid. It happens in peripheral tissues throughout your body—in the liver, kidneys, muscles, and especially the brain. The enzyme responsible for this vital activation step is called Type 2 Deiodinase, and it is encoded by the DIO2 gene.

This is where genetics re-enters the picture in a powerful way. A very common genetic variant, known as Thr92Ala (rs225014), exists in the DIO2 gene. Approximately 12-16% of the population carries two copies of this variant, and many more carry one. Research has shown that this variant can make the deiodinase enzyme less stable and efficient. Individuals with the Thr92Ala polymorphism may have a reduced ability to convert T4 to T3 within their cells (Castagna et al., 2017).

The result? Your blood tests for TSH and Free T4 might look perfect, but on a cellular level—especially in the brain, which relies heavily on local T3 conversion—you are functionally hypothyroid. This can explain the persistence of severe thyroid symptoms like brain fog, depression, and fatigue even when your doctor says your levels are fine.

Can Your Genes Affect Your Hypothyroidism Treatment?

Standard hypothyroidism treatment is levothyroxine, a synthetic version of T4. For most people, this works well. They take the T4, and their body converts what it needs into active T3.

But if you have the DIO2 Thr92Ala variant, T4-only therapy might leave you feeling chronically unwell. You're giving your body the raw material, but your cellular machinery for activating it is impaired. Studies have shown that patients with this genetic variant who are taking levothyroxine often report lower quality of life and prefer combination therapy (T4 plus a small amount of T3) over T4 monotherapy. This is a complex area of endocrinology, and a change in therapy should only be undertaken with close supervision from an experienced physician.

Beyond genetics, this crucial conversion process also depends on key micronutrients. The deiodinase enzymes are selenoenzymes, which means they require the mineral selenium as a critical component to function. A selenium deficiency can mimic or worsen the effects of the DIO2 variant, further hindering T4-to-T3 conversion. Furthermore, adequate selenium has been shown in some studies to help reduce TPO antibody levels in patients with Hashimoto's (Ventura et al., 2017).

Iodine is the other essential mineral, as it forms the backbone of the thyroid hormones themselves (T4 has four iodine atoms; T3 has three). While deficiency causes goiter and hypothyroidism, excess iodine in genetically susceptible individuals can actually trigger or worsen Hashimoto's.

Answering Your Questions About An Underactive Thyroid

What are common thyroid symptoms?

Symptoms of an underactive thyroid can be vague and overlap with many other conditions. They often develop slowly over years and may include: persistent fatigue, unexplained weight gain or difficulty losing weight, brain fog and poor concentration, feeling cold when others are not, dry skin and brittle nails, hair loss, depression or low mood, constipation, and muscle aches.

What does 'underactive thyroid' mean?

'Underactive thyroid' is the common term for hypothyroidism. It simply means your thyroid gland is not producing enough thyroid hormone to meet your body's metabolic needs. This can be due to an autoimmune attack (Hashimoto's), surgical removal of the thyroid, radiation treatment, or other less common causes.

Why is the TSH normal range so controversial?

The debate over the 'TSH normal range' stems from the observation that the population average TSH is around 1.5 mU/L. The upper limit of ~4.5 mU/L includes older individuals and those with undiagnosed, mild thyroid disease. Many experts now argue that a TSH above 2.5-3.0 mU/L in a younger person could indicate early thyroid failure, even if it's technically within the lab's reference range. Feeling your best often requires a more personalized approach than simply falling "somewhere" in a broad statistical range.

---

Navigating a hypothyroidism diagnosis is more than just normalizing a TSH value. It’s about restoring your quality of life. If your lab tests look fine but your symptoms persist, the explanation may be written in your DNA. Understanding your genetic predispositions for autoimmune thyroiditis (HLA, CTLA4, PTPN22) and your unique ability to process thyroid hormone (DIO2) provides a more complete picture of your health.

This knowledge can empower you to have more informed conversations with your doctor about testing, lifestyle interventions like optimizing selenium intake, and treatment strategies that are best suited to your unique biology. A genetic test doesn't provide a diagnosis, but it reveals your body's personal instruction manual, offering clues that can help solve the puzzle of persistent symptoms.

Equipo BioGenetic

References

1. Garber, J. R., et al. Thyroid. 2012. https://pubmed.ncbi.nlm.nih.gov/23055750/
2. Zivanovic, D., & Stamenkovic, H. Current Opinion in Immunology. 2017. https://pubmed.ncbi.nlm.nih.gov/28419883/
3. Castagna, M. G., et al. Endocrine. 2017. https://doi.org/10.1007/s12020-016-1192-9
4. Ventura, M., et al. International Journal of Endocrinology. 2017. https://pubmed.ncbi.nlm.nih.gov/28255299/